Model Number G247 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Unspecified Infection (1930); Swelling (2091); Fluid Discharge (2686); Swelling/ Edema (4577)
|
Event Date 02/22/2019 |
Event Type
Injury
|
Manufacturer Narrative
|
As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
|
|
Event Description
|
Boston scientific received information that this cardiac resynchronization therapy defibrillator (crt-d) was part of a system revision due to wound infection.Reportedly the patient presented to the emergency room (er) with complaint of swelling, redness and intermittent draining from incision site a few days after the staples were removed.The patient was prescribed with oral antibiotics for ten days and advised for a follow-up with physician the next day.There were no additional adverse patient effects reported.The crt-d remains in service.
|
|
Event Description
|
Boston scientific received information that this cardiac resynchronization therapy defibrillator (crt-d) was part of a system revision due to wound infection.Reportedly the patient presented to the emergency room (er) with complaint of swelling, redness and intermittent draining from incision site a few days after the staples were removed.The patient was prescribed with oral antibiotics for ten days and advised for a follow-up with physician the next day.There were no additional adverse patient effects reported.The crt-d remains in service.Additional information indicated that this cardiac resynchronization therapy defibrillator (crt-d) has been explanted due to infection.There were no additional adverse patient effects reported.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Upon receipt at our post market quality assurance laboratory, additional information from product investigation indicates that the allegation against this device was not confirmed.This device was analyzed, passed all the baseline tests and exhibited normal device functions.This supplemental is being filed to capture d9: returned to manufacturer date and investigation results.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Boston scientific received information that this cardiac resynchronization therapy defibrillator (crt-d) was part of a system revision due to wound infection.Reportedly the patient presented to the emergency room (er) with complaint of swelling, redness and intermittent draining from incision site a few days after the staples were removed.The patient was prescribed with oral antibiotics for ten days and advised for a follow-up with physician the next day.There were no additional adverse patient effects reported.The crt-d remains in service.Additional information indicated that this cardiac resynchronization therapy defibrillator (crt-d) has been explanted due to infection.There were no additional adverse patient effects reported.
|
|
Search Alerts/Recalls
|